Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10889 - 10896 of 12142 results

European Commission Proposes New Ground Rules for US Safe Harbor
November 28, 2013| Blog| Viewpoint

New York Federal Court Does and Doesn’t Address Contours of Employer Liability under the Federal and New York State WARN Acts
November 27, 2013| Blog| Viewpoint

Passive Leads Not Protected – New York Federal Court Rejects Enforcement of Non-Compete
November 26, 2013| Blog| Viewpoint

Omnicare Decision Addresses Section 11 Liability for Statements About Corporate Legal Compliance
November 25, 2013| Blog| Viewpoint

OIG Defines its Priorities in 2014-2018 Strategic Plan
November 25, 2013| Blog| Viewpoint

Taking Stock of Non-Competition Agreements – Assets to Consider When Purchasing a Company
November 25, 2013| Blog| Viewpoint

Google pays BIG to state Attorney Generals for Improper Consumer Tracking
November 22, 2013| Blog| Viewpoint

Treasury Department/IRS Issue Guidance Instructing Employers on How to Make Claims for FICA Refunds or Credits Post-Windsor
November 22, 2013| Advisory| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
